Zenith Healthcare (530665.BO) Stock Price

Zenith Healthcare Price

CLOSED
3.10
​
Market closed

Revenue has compounded at 10.1% per year over the past 12 years to 104.32 M INR. Earnings per share have declined at 39.2% per year over the last 8 years. Zenith Healthcare's net margin stands at 0.0%, down from 1.4% several years earlier.

Zenith Healthcare stock price

Access this data via the Eulerpool API

Zenith Healthcare business model & stock analysis

Zenith Healthcare Ltd. engages in the manufacture of pharmaceuticals formulation in the forms of tablets, capsules, oral liquids and injections. The company is headquartered in Ahmedabad, Gujarat. The firm offers its products across various therapeutic segments, including antibiotics and anti-infective, gastrointestinal tract, analgesic/anti-inflammatory, cardiovascular system, respiratory, ophthalmology, bio-technical products, oncology, anti-retroviral, central nervous system, nutrition, genito urinary system and skin. Its products across antibiotics and anti-infective categories include Roxythromycin Tablets, Ciprofloxacin Tablets, Azithromycine Dihydrate Suspension and Azithromycin Oral Suspension. Its product across the gastrointestinal category includes Ranitidine Hydrochloride Tablets. Its product across the cardiovascular system includes Lisinopril Tablets. Its products across the analgesic category include Paracetamol and Aceclofenac Tablets. The company offers contract manufacturing of all dosage forms.

Frequently asked questions about Zenith Healthcare

Converted at the current exchange rate, the Zenith Healthcare share trades at 0.03 EUR (3.10 INR).

The revenue of Zenith Healthcare is 104.32 M INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Zenith Healthcare is 51,000.00 INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Zenith Healthcare is currently 3,266.49. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Zenith Healthcare stock.

The price-to-sales ratio (P/S) of Zenith Healthcare is currently 1.60. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Zenith Healthcare stock.

The Eulerpool Quality Score for Zenith Healthcare is 2/10.

The ISIN of Zenith Healthcare is INE812B01026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Zenith Healthcare is 530665.BO. The ticker symbol is used to trade Zenith Healthcare shares on the stock exchange.

Fair ValueTerminal
2.88 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Apr 27, 1995
ISIN
INE812B01026
Cusip
Y9889K139
Market capitalization
166.59 M INRMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.24
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.07 %
Last updated Oct 11, 2026, 5:20 AM

Zenith Healthcare Peer Group

Zenith Healthcare FIGI

ZHC:IN · BBG000FDFXV1ZHC:IB · BBG000FDFYP6